Industry
Medical - Diagnostics & Research
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Loading...
Open
1.08
Mkt cap
5.8M
Volume
34K
High
1.08
P/E Ratio
-0.33
52-wk high
3.85
Low
1.00
Div yield
N/A
52-wk low
1.00
Portfolio Pulse from Avi Kapoor
March 26, 2024 | 5:45 pm
Portfolio Pulse from Benzinga Newsdesk
March 26, 2024 | 1:27 pm
Portfolio Pulse from Avi Kapoor
March 26, 2024 | 12:00 pm
Portfolio Pulse from Benzinga Newsdesk
March 26, 2024 | 6:56 am
Portfolio Pulse from Benzinga Newsdesk
December 29, 2023 | 2:02 pm
Portfolio Pulse from Benzinga Newsdesk
December 15, 2023 | 7:08 am
Portfolio Pulse from Benzinga Newsdesk
December 07, 2023 | 6:59 pm
Portfolio Pulse from Benzinga Newsdesk
December 05, 2023 | 8:56 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.